2022-07-012023-06-302023-06-30false10797601BEYOND BEAUTY & NAILS LTD2026-06-15falseiso4217:GBPxbrli:pure107976012022-06-30107976012023-06-30107976012022-07-012023-06-30107976012021-06-30107976012022-06-30107976012021-07-012022-06-3010797601bus:SmallEntities2022-07-012023-06-3010797601bus:AuditExempt-NoAccountantsReport2022-07-012023-06-3010797601bus:FullAccounts2022-07-012023-06-3010797601bus:PrivateLimitedCompanyLtd2022-07-012023-06-3010797601core:WithinOneYear2023-06-3010797601core:AfterOneYear2023-06-3010797601core:WithinOneYear2022-06-3010797601core:AfterOneYear2022-06-3010797601core:ShareCapital2023-06-3010797601core:SharePremium2023-06-3010797601core:RevaluationReserve2023-06-3010797601core:OtherReservesSubtotal2023-06-3010797601core:RetainedEarningsAccumulatedLosses2023-06-3010797601core:ShareCapital2022-06-3010797601core:SharePremium2022-06-3010797601core:RevaluationReserve2022-06-3010797601core:OtherReservesSubtotal2022-06-3010797601core:RetainedEarningsAccumulatedLosses2022-06-3010797601core:LandBuildings2023-06-3010797601core:PlantMachinery2023-06-3010797601core:Vehicles2023-06-3010797601core:FurnitureFittings2023-06-3010797601core:OfficeEquipment2023-06-3010797601core:NetGoodwill2023-06-3010797601core:IntangibleAssetsOtherThanGoodwill2023-06-3010797601core:ListedExchangeTraded2023-06-3010797601core:UnlistedNon-exchangeTraded2023-06-3010797601core:LandBuildings2022-06-3010797601core:PlantMachinery2022-06-3010797601core:Vehicles2022-06-3010797601core:FurnitureFittings2022-06-3010797601core:OfficeEquipment2022-06-3010797601core:NetGoodwill2022-06-3010797601core:IntangibleAssetsOtherThanGoodwill2022-06-3010797601core:ListedExchangeTraded2022-06-3010797601core:UnlistedNon-exchangeTraded2022-06-3010797601core:LandBuildings2022-07-012023-06-3010797601core:PlantMachinery2022-07-012023-06-3010797601core:Vehicles2022-07-012023-06-3010797601core:FurnitureFittings2022-07-012023-06-3010797601core:OfficeEquipment2022-07-012023-06-3010797601core:NetGoodwill2022-07-012023-06-3010797601core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3010797601core:ListedExchangeTraded2022-07-012023-06-3010797601core:UnlistedNon-exchangeTraded2022-07-012023-06-3010797601core:MoreThanFiveYears2022-07-012023-06-3010797601core:Non-currentFinancialInstruments2023-06-3010797601core:Non-currentFinancialInstruments2022-06-3010797601dpl:CostSales2022-07-012023-06-3010797601dpl:DistributionCosts2022-07-012023-06-3010797601core:LandBuildings2022-07-012023-06-3010797601core:PlantMachinery2022-07-012023-06-3010797601core:Vehicles2022-07-012023-06-3010797601core:FurnitureFittings2022-07-012023-06-3010797601core:OfficeEquipment2022-07-012023-06-3010797601dpl:AdministrativeExpenses2022-07-012023-06-3010797601core:NetGoodwill2022-07-012023-06-3010797601core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3010797601dpl:GroupUndertakings2022-07-012023-06-3010797601dpl:ParticipatingInterests2022-07-012023-06-3010797601dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3010797601core:ListedExchangeTraded2022-07-012023-06-3010797601dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3010797601core:UnlistedNon-exchangeTraded2022-07-012023-06-3010797601dpl:CostSales2021-07-012022-06-3010797601dpl:DistributionCosts2021-07-012022-06-3010797601core:LandBuildings2021-07-012022-06-3010797601core:PlantMachinery2021-07-012022-06-3010797601core:Vehicles2021-07-012022-06-3010797601core:FurnitureFittings2021-07-012022-06-3010797601core:OfficeEquipment2021-07-012022-06-3010797601dpl:AdministrativeExpenses2021-07-012022-06-3010797601core:NetGoodwill2021-07-012022-06-3010797601core:IntangibleAssetsOtherThanGoodwill2021-07-012022-06-3010797601dpl:GroupUndertakings2021-07-012022-06-3010797601dpl:ParticipatingInterests2021-07-012022-06-3010797601dpl:GroupUndertakingscore:ListedExchangeTraded2021-07-012022-06-3010797601core:ListedExchangeTraded2021-07-012022-06-3010797601dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-07-012022-06-3010797601core:UnlistedNon-exchangeTraded2021-07-012022-06-3010797601core:NetGoodwill2023-06-3010797601core:IntangibleAssetsOtherThanGoodwill2023-06-3010797601core:LandBuildings2023-06-3010797601core:PlantMachinery2023-06-3010797601core:Vehicles2023-06-3010797601core:FurnitureFittings2023-06-3010797601core:OfficeEquipment2023-06-3010797601core:AfterOneYear2023-06-3010797601core:WithinOneYear2023-06-3010797601core:ListedExchangeTraded2023-06-3010797601core:UnlistedNon-exchangeTraded2023-06-3010797601core:ShareCapital2023-06-3010797601core:SharePremium2023-06-3010797601core:RevaluationReserve2023-06-3010797601core:OtherReservesSubtotal2023-06-3010797601core:RetainedEarningsAccumulatedLosses2023-06-3010797601core:NetGoodwill2022-06-3010797601core:IntangibleAssetsOtherThanGoodwill2022-06-3010797601core:LandBuildings2022-06-3010797601core:PlantMachinery2022-06-3010797601core:Vehicles2022-06-3010797601core:FurnitureFittings2022-06-3010797601core:OfficeEquipment2022-06-3010797601core:AfterOneYear2022-06-3010797601core:WithinOneYear2022-06-3010797601core:ListedExchangeTraded2022-06-3010797601core:UnlistedNon-exchangeTraded2022-06-3010797601core:ShareCapital2022-06-3010797601core:SharePremium2022-06-3010797601core:RevaluationReserve2022-06-3010797601core:OtherReservesSubtotal2022-06-3010797601core:RetainedEarningsAccumulatedLosses2022-06-3010797601core:NetGoodwill2021-06-3010797601core:IntangibleAssetsOtherThanGoodwill2021-06-3010797601core:LandBuildings2021-06-3010797601core:PlantMachinery2021-06-3010797601core:Vehicles2021-06-3010797601core:FurnitureFittings2021-06-3010797601core:OfficeEquipment2021-06-3010797601core:AfterOneYear2021-06-3010797601core:WithinOneYear2021-06-3010797601core:ListedExchangeTraded2021-06-3010797601core:UnlistedNon-exchangeTraded2021-06-3010797601core:ShareCapital2021-06-3010797601core:SharePremium2021-06-3010797601core:RevaluationReserve2021-06-3010797601core:OtherReservesSubtotal2021-06-3010797601core:RetainedEarningsAccumulatedLosses2021-06-3010797601core:AfterOneYear2022-07-012023-06-3010797601core:WithinOneYear2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:CostValuation2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3010797601core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3010797601core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3010797601core:Non-currentFinancialInstrumentscore:CostValuation2022-06-3010797601core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-06-3010797601core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-06-3010797601core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-06-3010797601core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-06-3010797601core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-06-3010797601core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-06-3010797601core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-06-3010797601core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-06-3010797601bus:Director12022-07-012023-06-30

BEYOND BEAUTY & NAILS LTD

Registered Number
10797601
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2023

BEYOND BEAUTY & NAILS LTD
Company Information
for the year from 1 July 2022 to 30 June 2023

Director

HALL, Lucie

Registered Address

61 Bridge Street
Kington
HR5 3DJ

Registered Number

10797601 (England and Wales)
BEYOND BEAUTY & NAILS LTD
Balance Sheet as at
30 June 2023

Notes

2023

2022

£

£

£

£

Current assets
Cash at bank and on hand342435
342435
Creditors amounts falling due within one year4(2,688)(2,193)
Net current assets (liabilities)(2,346)(1,758)
Total assets less current liabilities(2,346)(1,758)
Creditors amounts falling due after one year5(18,024)(18,097)
Net assets(20,370)(19,855)
Capital and reserves
Called up share capital100100
Profit and loss account(20,470)(19,955)
Shareholders' funds(20,370)(19,855)
The financial statements were approved and authorised for issue by the Director on 15 June 2026, and are signed on its behalf by:
HALL, Lucie
Director
Registered Company No. 10797601
BEYOND BEAUTY & NAILS LTD
Notes to the Financial Statements
for the year ended 30 June 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20232022
Average number of employees during the year22
3.Stocks
4.Creditors: amounts due within one year

2023

2022

££
Other creditors2,1382,193
Accrued liabilities and deferred income550-
Total2,6882,193
5.Creditors: amounts due after one year

2023

2022

££
Bank borrowings and overdrafts18,02418,097
Total18,02418,097
6.Related party transactions
At the balance sheet date, the company owed a director £2,138 (2022: £2,193).